Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,140 | 68 | 51.7% |
| Travel and Lodging | $2,002 | 3 | 48.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Smith+Nephew, Inc. | $1,566 | 6 | $0 (2022) |
| Medical Device Business Services, Inc. | $815.39 | 1 | $0 (2019) |
| GlaxoSmithKline, LLC. | $291.61 | 12 | $0 (2024) |
| Intersect ENT, Inc. | $279.80 | 4 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $266.95 | 11 | $0 (2024) |
| AERIN MEDICAL INC. | $234.97 | 9 | $0 (2024) |
| Optinose US, Inc. | $228.40 | 12 | $0 (2024) |
| Stryker Corporation | $151.80 | 2 | $0 (2022) |
| Acclarent, Inc | $111.11 | 2 | $0 (2021) |
| GENZYME CORPORATION | $90.68 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $302.65 | 14 | Optinose US, Inc. ($81.24) |
| 2023 | $483.91 | 19 | Regeneron Healthcare Solutions, Inc. ($170.35) |
| 2022 | $1,829 | 15 | Smith+Nephew, Inc. ($1,566) |
| 2021 | $287.41 | 12 | Acclarent, Inc ($111.11) |
| 2020 | $143.34 | 3 | Stryker Corporation ($113.73) |
| 2019 | $1,074 | 6 | Medical Device Business Services, Inc. ($815.39) |
| 2018 | $22.82 | 2 | GlaxoSmithKline, LLC. ($12.04) |
All Payment Transactions
71 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: IMMUNOLOGY | ||||||
| 09/06/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device), RHINAER STYLUS | Food and Beverage | In-kind items and services | $37.28 | General |
| Category: EAR NOSE & THROAT | ||||||
| 08/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/07/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 07/10/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device), RHINAER STYLUS | Food and Beverage | In-kind items and services | $33.96 | General |
| Category: EAR NOSE & THROAT | ||||||
| 06/11/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: IMMUNOLOGY | ||||||
| 05/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Immunology | ||||||
| 05/10/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 03/29/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 03/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Immunology | ||||||
| 03/06/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: IMMUNOLOGY | ||||||
| 02/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Immunology | ||||||
| 01/26/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $25.49 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/11/2023 | AERIN MEDICAL INC. | VIVAER STYLUS (Device), RHINAER STYLUS | Food and Beverage | In-kind items and services | $10.10 | General |
| Category: EAR NOSE & THROAT | ||||||
| 12/08/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2023 | AERIN MEDICAL INC. | VIVAER STYLUS (Device), RHINAER STYLUS | Food and Beverage | In-kind items and services | $31.31 | General |
| Category: EAR NOSE & THROAT | ||||||
| 11/03/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/15/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Immunology | ||||||
| 08/09/2023 | AERIN MEDICAL INC. | VIVAER STYLUS (Device), RHINAER STYLUS | Food and Beverage | In-kind items and services | $37.36 | General |
| Category: EAR NOSE & THROAT | ||||||
| 08/07/2023 | AERIN MEDICAL INC. | VIVAER STYLUS (Device), RHINAER STYLUS | Food and Beverage | In-kind items and services | $10.10 | General |
| Category: EAR NOSE & THROAT | ||||||
| 07/14/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Immunology | ||||||
| 06/30/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 06/22/2023 | AERIN MEDICAL INC. | VIVAER STYLUS (Device), RHINAER STYLUS | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: EAR NOSE & THROAT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 369 | 525 | $219,650 | $52,084 |
| 2022 | 8 | 300 | 403 | $159,816 | $40,029 |
| 2021 | 4 | 70 | 78 | $28,949 | $6,879 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 87 | 174 | $63,350 | $19,072 | 30.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 89 | 89 | $49,039 | $11,593 | 23.6% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 37 | 53 | $43,089 | $8,194 | 19.0% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 44 | 72 | $30,960 | $7,980 | 25.8% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 68 | 79 | $24,934 | $2,904 | 11.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 16 | $3,952 | $1,271 | 32.2% |
| 92504 | Exam of ear using a microscope | Office | 2023 | 32 | 42 | $4,326 | $1,070 | 24.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 79 | 79 | $43,529 | $10,909 | 25.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 52 | 93 | $33,759 | $10,395 | 30.8% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 37 | 55 | $23,650 | $6,111 | 25.8% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 23 | 34 | $27,642 | $5,793 | 21.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 42 | $10,374 | $3,413 | 32.9% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 44 | 58 | $17,108 | $2,174 | 12.7% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 25 | 26 | $2,106 | $796.69 | 37.8% |
| 92504 | Exam of ear using a microscope | Office | 2022 | 13 | 16 | $1,648 | $437.51 | 26.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 23 | 23 | $12,673 | $3,164 | 25.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 18 | $4,446 | $1,486 | 33.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 14 | 14 | $5,096 | $1,318 | 25.9% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 19 | 23 | $6,734 | $910.78 | 13.5% |
About Dr. Jonathan Cohen, MD
Dr. Jonathan Cohen, MD is a Otolaryngology healthcare provider based in New Providence, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2008. The National Provider Identifier (NPI) number assigned to this provider is 1497915292.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Cohen, MD has received a total of $4,142 in payments from pharmaceutical and medical device companies, with $302.65 received in 2024. These payments were reported across 71 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($2,140).
As a Medicare-enrolled provider, Cohen has provided services to 739 Medicare beneficiaries, totaling 1,006 services with total Medicare billing of $98,992. Data is available for 3 years (2021–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Otolaryngology
- Other Specialties Otolaryngology
- Location New Providence, NJ
- Active Since 06/15/2008
- Last Updated 08/23/2021
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1497915292
Products in Payments
- Coblation (Device) $1,491
- DUPIXENT (Biological) $357.63
- NUCALA (Biological) $279.57
- VIVAER STYLUS (Device) $234.97
- Xhance (Drug) $228.40
- PROPEL (Device) $225.49
- GAMMA (Device) $113.73
- Relieva Spinplus (Device) $111.11
- HALO (Device) $75.23
- SINUVA (Drug) $71.34
- ALVESCO (Drug) $58.15
- XPRESS ENT DILATION SYSTEM (Device) $38.07
- CIPRODEX (Drug) $15.00
- BREO (Drug) $12.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.